Case number 1:21-cv-00489
United Therapeutics Corporation et al v. ANI Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 26, 2022 | 48 | Order (1) |
| May 26, 2022 | 48 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,417,070 B2; 7,544,713 B2; 8,252,839 B2; 8,349,892 B2; 8,410,169 B2; 8,747,897 B2; 9,050,311 B2; 9,278,901 B2; 9,393,203 B2; 9,422,223 B2; 9,593,066 B2; 9,604,901 B2. (Attachments: # (1) Order)(nms) |
| May 26, 2022 | 47 | Order (1) Docket Text: SO ORDERED Granting [46] Stipulation of Dismissal Without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 5/26/2022. (nms) |
| May 26, 2022 | 46 | Stipulation of Dismissal (1) Docket Text: STIPULATION of Dismissal Without Prejudice, by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) Modified on 5/26/2022 (nms). |
| Apr 21, 2022 | 45 | Order (2) Docket Text: SO ORDERED Granting [44] Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 4/21/2022. (nms) |
| Apr 20, 2022 | 44 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction - by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Mar 18, 2022 | 43 | Redacted Document (30) Docket Text: REDACTED VERSION of [42] Notice Subpoena, by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) Modified on 3/21/2022 (nms). |
| Mar 3, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [39] Order Setting Mediation Conferences: Pursuant to the Court's Announcement dated March 3, 2022, IT IS ORDERED THAT the 10/17/2022 mediation teleconference and the 12/1/2022 mediation conference, and all associated deadlines and submissions, are hereby CANCELLED. Ordered by Judge Mary Pat Thynge on 3/3/2022. (Taylor, Daniel) |
| Feb 18, 2022 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production to Defendant ANI Pharmaceuticals, Inc. (Nos. 78-93) - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Feb 11, 2022 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Feb 9, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdfs for the exhibits found at D.I. [38] has been replaced per the filers request. Exhibit B has been corrected. The NEF for the filing has been regenerated. (nms) |
| Feb 1, 2022 | 39 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conferences: A Virtual/Video Mediation Conference is set for 12/1/2022 at 11:00 AM Eastern before Judge Mary Pat Thynge. See ORDER for details. Signed by Judge Mary Pat Thynge on 2/1/2022. (Taylor, Daniel) |
| Feb 1, 2022 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER Setting Mediation Conferences: A Telephone Conference re: Mediation is set for 10/17/2022 at 11:30 AM Eastern before Judge Mary Pat Thynge. The purpose of the telephone call is to check in to determine whether the 12/1/2022 mediation shall proceed as scheduled. Counsel shall determine who will coordinate the teleconference and arrange the call to chambers. Ordered by Judge Mary Pat Thynge on 2/1/2022. (Taylor, Daniel) |
| Jan 21, 2022 | 38 | Exs. B-G (538) |
| Jan 21, 2022 | 38 | Main Document (14) Docket Text: Joint Claim Construction Chart, by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Attachments: # (1) Exhibits B-G)(Flynn, Michael) Modified on 1/24/2022 (nms). (Attachment 1 replaced on 2/9/2022) (nms). |
| Jan 21, 2022 | 37 | Order (2) Docket Text: SO ORDERED Granting [36] Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 1/21/2022. (nms) |
| Jan 21, 2022 | 36 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction - by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Jan 18, 2022 | 35 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant ANI Pharmaceuticals, Inc.'s Proposed Claim Constructions filed by ANI Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Jan 10, 2022 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER Setting Mediation Conferences: IT IS ORDERED THAT a Telephone Conference re: Mediation is set for 1/24/2022 at 10:30 AM Eastern before Judge Mary Pat Thynge. Counsel for defendant shall initiate the call to chambers. Ordered by Judge Mary Pat Thynge on 1/10/2022. (Taylor, Daniel) |
| Jan 3, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendants Interrogatories to Plaintiffs (Set 1, Nos. 1-8) filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Dec 13, 2021 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1- Defendant ANI Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (No. 1); and 2- Defendant ANI Pharmaceuticals, Inc.'s First Set of Interrogatories to Plaintiffs (Nos. 1-8) filed by ANI Pharmaceuticals, Inc..(Keller, Karen) |
| Dec 13, 2021 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant ANI Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 2-8) filed by ANI Pharmaceuticals, Inc..(Keller, Karen) |
| Nov 17, 2021 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant ANI Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-56) - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Nov 9, 2021 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff United Therapeutics Corporation's Second Set of Interrogatories to ANI Pharmaceuticals, Inc. (Nos. 2-8) - filed by United Therapeutics Corporation.(Flynn, Michael) |
| Nov 2, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories to ANI Pharmaceuticals, Inc. (No. 1) filed by United Therapeutics Corporation.(Flynn, Michael) |
| Oct 19, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant ANI Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 156) (2) Defendant ANI Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Production filed by ANI Pharmaceuticals, Inc..(Keller, Karen) |
| Oct 18, 2021 | 26 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Infringement Contentions - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Sep 16, 2021 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Defendant ANI Pharmaceuticals, Inc. (Nos. 1 - 77) - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Aug 19, 2021 | 24 | Order (21) Docket Text: SO ORDERED Granting [23] Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/19/2021. (nms) |
| Aug 18, 2021 | 23 | Proposed Order (21) Docket Text: PROPOSED Stipulated Protective Order, by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) Modified on 8/19/2021 (nms). |
| Aug 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim, Jiaxiao Zhang and Art Dykhuis, filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 8/13/2021. (nms) |
| Aug 12, 2021 | 22 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mandy H. Kim, Jiaxiao Zhang and Art Dykhuis - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Aug 11, 2021 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant ANI Pharmaceuticals, Inc.'s Initial Disclosures filed by ANI Pharmaceuticals, Inc..(Keller, Karen) |
| Aug 11, 2021 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(A) of the Delaware Default Standard for Discovery, (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery and (3) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Jul 21, 2021 | 19 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Jul 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson, filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 7/21/2021. (nms) |
| Jun 25, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher B. Essig for ANI Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jun 25, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER : This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 6/25/2021. (Taylor, Daniel) |
| Jun 25, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Jun 24, 2021 | 18 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Essig - filed by ANI Pharmaceuticals, Inc.. (Keller, Karen) |
| Jun 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Essig, filed by ANI Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 6/24/2021. (nms) |
| Jun 24, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael A. Meneghini and Kurt A. Mathas for ANI Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jun 23, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 6/24/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 6/23/2021. (nms) |
| Jun 23, 2021 | 16 | Scheduling Order (10) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 6/4/2022. Amended Pleadings due by 6/4/2022. Fact Discovery completed by 10/14/2022. Joint Claim Construction Brief due by 4/22/2022. A Markman Hearing is set for 5/26/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/28/2023, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 5/8/2023, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/23/2021. (nms) |
| Jun 23, 2021 | 15 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kurt A. Mathas and Michael A. Meneghini - filed by ANI Pharmaceuticals, Inc.. (Keller, Karen) |
| Jun 23, 2021 | 14 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Michael Flynn regarding dial-in information for the Scheduling Conference on Thursday, June 24, 2021. (Flynn, Michael) |
| Jun 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Kurt A. Mathas and Michael A. Meneghini, filed by ANI Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 6/23/2021. (nms) |
| Jun 22, 2021 | 13 | Letter to The Honorable Richard G. Andrews (1) |
| Jun 22, 2021 | 13 | Main Document (10) Docket Text: PROPOSED Scheduling Order, by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Attachments: # (1) Letter)(Flynn, Michael) Modified on 6/22/2021 (nms). |
| Jun 18, 2021 | 12 | Answer to Counterclaim (30) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation.(Flynn, Michael) |
| Jun 4, 2021 | 11 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 6/24/2021, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 6/4/2021. (nms) |
| May 28, 2021 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for ANI Pharmaceuticals, Inc. filed by ANI Pharmaceuticals, Inc.. (Keller, Karen) |
| May 28, 2021 | 9 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Supernus Pharmaceuticals, Inc., United Therapeutics Corporation, by ANI Pharmaceuticals, Inc..(Keller, Karen) Modified on 5/28/2021 (nms). |
| Apr 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: ANI Pharmaceuticals, Inc. answer due 6/26/2021). Signed by Judge Richard G. Andrews on 4/26/2021. (nms) |
| Apr 23, 2021 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for defendant to respond to the Complaint to June 25, 2021 - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Apr 7, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Apr 5, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by United Therapeutics Corporation, Supernus Pharmaceuticals, Inc.. ANI Pharmaceuticals, Inc. served on 4/5/2021, answer due 4/26/2021. (Blumenfeld, Jack) |
| Apr 1, 2021 | 1 | Main Document (38) Docket Text: COMPLAINT filed against ANI Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3584393.) - filed by United Therapeutics Corporation, Supernus Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-L, # (2) Civil Cover Sheet)(myr) |
| Apr 1, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Apr 1, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate The Vanguard Group, Inc., Other Affiliate BlackRock Institutional Trust Company for Supernus Pharmaceuticals, Inc.; Other Affiliate BlackRock Inc. for United Therapeutics Corporation filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (myr) |
| Apr 1, 2021 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (myr) |
| Apr 1, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 23, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/23/2023. (myr) |
| Apr 1, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Apr 1, 2021 | 1 | Civil Cover Sheet (1) |
| Apr 1, 2021 | 1 | Exhibit A-L (509) |
| Apr 1, 2021 | 1 | Complaint* (1) |
